The Kaplan–Meier analysis also revealed that cats with mammary carcinoma showing higher serum TIM-3+ levels had a more favorable prognostic outcome than those with lower serum TIM-3+ (p = 0.033). This evidence concerns the gene HAVCR2 and breast carcinoma.